Tag archive for ‘Needham’
Globes On Thursday, July 31st, 2014

VBL Therapeutics prices Nasdaq IPO

– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing of its Nasdaq IPO. The company is selling More...

CFO Eyal Desheh, TEVA
Shiri Habib-Valdhorn On Thursday, December 5th, 2013

Analysts Unenthusiastic Over Teva’s NTE Products

– Teva sees $3 billion in potential sales by 2020 from 50 new therapeutic entities. – Dr. Michael Hayden – 50 new products with $3 billion in potential sales in 2020 is the news delivered More...

Wordpress site Developed by Fixing WordPress Problems